US OptionsDetailed Quotes
REGN250502P520000
- 0.03
- -0.82-96.47%
15min DelayClose May 2 16:00 ET
0.03High0.03Low
0.03Open0.85Pre Close8 Volume67 Open Interest520.00Strike Price24.00Turnover4242.04%IV14.14%PremiumMay 2, 2025Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type-0.0029Delta0.0003Gamma20187.00Leverage Ratio-199.2506Theta0.0000Rho-58.34Eff Leverage0.0001Vega
Regeneron Pharmaceuticals Stock Discussion
Sign in to post a comment
Morning Movers
Gapping Up
$Hims & Hers Health (HIMS.US)$ Hims & Hers surged 34.1% and $Novo-Nordisk A/S (NVO.US)$ increased by 4%. This followed Novo Nordisk's announcement that it will broaden the availability of its weight loss drug Wegovy by offering it through telehealth providers Hims & Hers Health, Ro, and Life MD, now that the drug is no longer facing shortages in the U.S.
$SoFi Technologies (SOFI.US)$ stock rose 5.9% after...
Gapping Up
$Hims & Hers Health (HIMS.US)$ Hims & Hers surged 34.1% and $Novo-Nordisk A/S (NVO.US)$ increased by 4%. This followed Novo Nordisk's announcement that it will broaden the availability of its weight loss drug Wegovy by offering it through telehealth providers Hims & Hers Health, Ro, and Life MD, now that the drug is no longer facing shortages in the U.S.
$SoFi Technologies (SOFI.US)$ stock rose 5.9% after...
19
1
9
$Regeneron Pharmaceuticals (REGN.US)$
Breakthrough: FDA Clears Dupixent for 300,000 Chronic Urticaria Patients After Decade-Long Wait
Breakthrough: FDA Clears Dupixent for 300,000 Chronic Urticaria Patients After Decade-Long Wait
$Regeneron Pharmaceuticals (REGN.US)$ Sold my trading position at 734. Put a limit buy order at around 600 to wait for the gap fill. The 200 week moving average is a key resistance. The company has to prove the Eylea franchise revenue will not be significantly eroded by biosimilars.
2
$Regeneron Pharmaceuticals (REGN.US)$
Can Dupixent Transform Rare Skin Disease Treatment? New Trial Data Reveals Breakthrough
Can Dupixent Transform Rare Skin Disease Treatment? New Trial Data Reveals Breakthrough
1
$Regeneron Pharmaceuticals (REGN.US)$ higher low?
2
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$Regeneron Pharmaceuticals (REGN.US)$
Regeneron's Multiple Myeloma Drug Clears Critical EU Regulatory Hurdle - What's Next?
Regeneron's Multiple Myeloma Drug Clears Critical EU Regulatory Hurdle - What's Next?
$Regeneron Pharmaceuticals (REGN.US)$
Can Regeneron's Cancer Drug With 80% Response Rate Secure FDA Approval For Lymphoma?
Can Regeneron's Cancer Drug With 80% Response Rate Secure FDA Approval For Lymphoma?
$Regeneron Pharmaceuticals (REGN.US)$
Revolutionary Hearing Breakthrough: Can This Gene Therapy End Childhood Genetic Deafness?
Revolutionary Hearing Breakthrough: Can This Gene Therapy End Childhood Genetic Deafness?
1
$Novo-Nordisk A/S (NVO.US)$ $Moderna (MRNA.US)$ $Johnson & Johnson (JNJ.US)$ $Netflix (NFLX.US)$ $Uber Technologies (UBER.US)$ $Grab Holdings (GRAB.US)$ $ParkwayLife Reit (C2PU.SG)$ $Tempus AI (TEM.US)$ $Serve Robotics (SERV.US)$ $Tesla (TSLA.US)$ $Regeneron Pharmaceuticals (REGN.US)$ $Amgen (AMGN.US)$
6
$Regeneron Pharmaceuticals (REGN.US)$ In traditional technical analysis, you would think this is likely reversed given the engulfing pattern with strong volume at an earnings event. But in this trending market, a higher high has to be established.
2
No comment yet
skumaar42 : Great info!